These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36661666)
1. Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study. Liu Z; Huang L; Wang H; Shi Z; Huang Y; Liang L; Wang R; Hu K Curr Oncol; 2022 Dec; 30(1):219-232. PubMed ID: 36661666 [TBL] [Abstract][Full Text] [Related]
2. Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose. Zhu MY; Wu HJ; Miao JJ; Di MP; Chen BY; Huang HG; Mai HQ; Wang L; Zhao C Oral Oncol; 2021 Sep; 120():105378. PubMed ID: 34174518 [TBL] [Abstract][Full Text] [Related]
3. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era. Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056 [TBL] [Abstract][Full Text] [Related]
4. Prediction of severe radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma using the combined systemic immune-inflammatory index and prognostic nutritional index. Song J; Wen Y; Liang L; Lv Y; Liu T; Wang R; Hu K Eur Arch Otorhinolaryngol; 2024 May; 281(5):2627-2635. PubMed ID: 38472492 [TBL] [Abstract][Full Text] [Related]
5. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis. Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182 [TBL] [Abstract][Full Text] [Related]
6. Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients. Zhang LL; Li YY; Hu J; Zhou GQ; Chen L; Li WF; Lin AH; Ma J; Qi ZY; Sun Y Cancer Res Treat; 2018 Oct; 50(4):1084-1095. PubMed ID: 29141396 [TBL] [Abstract][Full Text] [Related]
7. Incidence and Risk Factors for Radiotherapy-Induced Oral Mucositis Among Patients With Nasopharyngeal Carcinoma: A Meta-Analysis. Li J; Zhu C; Zhang Y; Guan C; Wang Q; Ding Y; Hu X Asian Nurs Res (Korean Soc Nurs Sci); 2023 May; 17(2):70-82. PubMed ID: 37094771 [TBL] [Abstract][Full Text] [Related]
8. The predictive value of hematological inflammatory markers for severe oral mucositis in patients with nasopharyngeal carcinoma during intensity-modulated radiation therapy: A retrospective cohort study. Huang X; Qin X; Huang W; Huang B Curr Probl Cancer; 2024 Aug; 51():101117. PubMed ID: 38945022 [TBL] [Abstract][Full Text] [Related]
9. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma. Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454 [TBL] [Abstract][Full Text] [Related]
10. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy. Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma. Jiang Y; Qu S; Pan X; Huang S; Zhu X Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045 [TBL] [Abstract][Full Text] [Related]
12. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose. Huang YY; Zhou JY; Zhan ZJ; Ke LR; Xia WX; Cao X; Cai ZC; Deng Y; Chen X; Zhang LL; Huang HY; Guo X; Lv X BMC Cancer; 2023 May; 23(1):410. PubMed ID: 37149594 [TBL] [Abstract][Full Text] [Related]
13. Nomogram Based on Clinical and Radiomics Data for Predicting Radiation-induced Temporal Lobe Injury in Patients with Non-metastatic Stage T4 Nasopharyngeal Carcinoma. Bin X; Zhu C; Tang Y; Li R; Ding Q; Xia W; Tang Y; Tang X; Yao D; Tang A Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e482-e492. PubMed ID: 36008245 [TBL] [Abstract][Full Text] [Related]
14. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy. Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma. Yan JJ; Guo SS; Lin DF; Liu LT; Liu SL; Xiao BB; Yang JH; Wen DX; Yang ZC; Liang YJ; Tang QN; Lin C; Li XY; Sun XS; Li JB; Tang LQ; Chen QY; Mai HQ Radiother Oncol; 2021 Jul; 160():9-17. PubMed ID: 33839205 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma. Chen G; Jiang H; Jiang D; Wu Q; Li Z; Hua X; Hu X; Zhao H; Wang X; Yu H; Xie C; Zhong Y Head Neck; 2021 Apr; 43(4):1153-1160. PubMed ID: 33300654 [TBL] [Abstract][Full Text] [Related]
17. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China. Wen DW; Lin L; Mao YP; Chen CY; Chen FP; Wu CF; Huang XD; Li ZX; Xu SS; Kou J; Yang XL; Ma J; Sun Y; Zhou GQ Radiother Oncol; 2021 Apr; 157():99-105. PubMed ID: 33484752 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients. Zhao DW; Teng F; Meng LL; Fan WJ; Luo YR; Jiang HY; Chen NX; Zhang XX; Yu W; Cai BN; Zhao LJ; Wang PG; Ma L Radiother Oncol; 2023 Jul; 184():109683. PubMed ID: 37120102 [TBL] [Abstract][Full Text] [Related]
19. Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy. Chen L; Li J; Li K; Hu J; Li Q; Huang C; Wang G; Liu N; Tang L Radiother Oncol; 2024 Jan; 190():109985. PubMed ID: 37926330 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial. Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]